Alphatec (ATEC) Competitors $14.90 -0.30 (-1.97%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$14.46 -0.44 (-2.92%) As of 04:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ATEC vs. GMED, TFX, ITGR, ATRC, IART, SRDX, OFIX, ANGO, ARAY, and RMTIShould you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Globus Medical (GMED), Teleflex (TFX), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Surmodics (SRDX), ORTHOFIX MEDICAL (OFIX), AngioDynamics (ANGO), Accuray (ARAY), and Rockwell Medical (RMTI). These companies are all part of the "health care equipment" industry. Alphatec vs. Its Competitors Globus Medical Teleflex Integer AtriCure Integra LifeSciences Surmodics ORTHOFIX MEDICAL AngioDynamics Accuray Rockwell Medical Alphatec (NASDAQ:ATEC) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Do institutionals and insiders hold more shares of ATEC or GMED? 66.3% of Alphatec shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 20.9% of Alphatec shares are owned by insiders. Comparatively, 18.5% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, ATEC or GMED? Alphatec has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Does the media favor ATEC or GMED? In the previous week, Alphatec had 19 more articles in the media than Globus Medical. MarketBeat recorded 32 mentions for Alphatec and 13 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.10 beat Alphatec's score of 0.27 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 10 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Globus Medical 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Is ATEC or GMED more profitable? Globus Medical has a net margin of 7.39% compared to Alphatec's net margin of -24.33%. Globus Medical's return on equity of 10.52% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Alphatec-24.33% -1,657.19% -21.44% Globus Medical 7.39%10.52%8.56% Which has stronger earnings and valuation, ATEC or GMED? Globus Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlphatec$682.24M3.23-$162.12M-$1.13-13.19Globus Medical$2.52B2.91$102.98M$1.3440.42 Do analysts recommend ATEC or GMED? Alphatec currently has a consensus price target of $18.50, suggesting a potential upside of 24.16%. Globus Medical has a consensus price target of $90.09, suggesting a potential upside of 66.33%. Given Globus Medical's higher possible upside, analysts clearly believe Globus Medical is more favorable than Alphatec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alphatec 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Globus Medical 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62 SummaryGlobus Medical beats Alphatec on 12 of the 16 factors compared between the two stocks. Get Alphatec News Delivered to You Automatically Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATEC vs. The Competition Export to ExcelMetricAlphatecMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.25B$6.80B$5.48B$9.57BDividend YieldN/A1.35%3.99%4.18%P/E Ratio-13.1924.4429.8725.14Price / Sales3.2359.23422.9397.17Price / CashN/A20.5535.9458.58Price / Book93.135.528.105.59Net Income-$162.12M$178.18M$3.26B$265.48M7 Day Performance8.21%-0.57%0.64%1.22%1 Month Performance28.45%-5.36%2.42%0.39%1 Year Performance135.39%6.18%27.60%23.47% Alphatec Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATECAlphatec3.7471 of 5 stars$14.90-2.0%$18.50+24.2%+144.3%$2.25B$682.24M-13.19700Trending NewsInsider TradeGMEDGlobus Medical4.8421 of 5 stars$53.64+1.9%$90.09+68.0%-23.3%$7.13B$2.52B16.985,300Positive NewsEarnings ReportTFXTeleflex4.6255 of 5 stars$116.24+0.3%$141.57+21.8%-48.8%$5.12B$3.05B8.2714,100News CoverageInsider TradeITGRInteger3.4324 of 5 stars$106.98+0.4%$140.25+31.1%-6.4%$3.73B$1.72B18.6211,000Positive NewsATRCAtriCure3.4894 of 5 stars$36.35+5.6%$50.89+40.0%+76.5%$1.71B$465.31M0.001,300IARTIntegra LifeSciences4.258 of 5 stars$12.56+2.0%$18.63+48.3%-41.8%$956.64M$1.61B5.504,396Positive NewsSRDXSurmodics3.5961 of 5 stars$35.63-1.1%$43.00+20.7%-14.7%$515.20M$126.08M0.00450Positive NewsHigh Trading VolumeOFIXORTHOFIX MEDICAL2.1854 of 5 stars$10.85+0.7%$21.50+98.2%-23.5%$421.98M$799.49M0.001,616News CoverageEarnings ReportANGOAngioDynamics3.9727 of 5 stars$8.67+1.3%$19.00+119.1%+18.1%$347.83M$292.50M0.00760Analyst RevisionARAYAccuray3.5047 of 5 stars$1.29+0.8%N/A-12.0%$144.18M$446.55M0.001,040Upcoming EarningsRMTIRockwell Medical4.189 of 5 stars$0.99+3.8%$4.00+303.2%-44.6%$32.67M$101.49M0.00300Upcoming EarningsGap Up Related Companies and Tools Related Companies GMED Alternatives TFX Alternatives ITGR Alternatives ATRC Alternatives IART Alternatives SRDX Alternatives OFIX Alternatives ANGO Alternatives ARAY Alternatives RMTI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATEC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alphatec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
